Furthermore, the results of immunohistochemistry revealed clearly that MDA-MB-231 cell lines were estrogen receptor negative (ER (−)), progesterone receptor negative (PR (−)), and human epidermal growth factor receptor-2 negative (HER-2 (−)), retaining the triple-negative expression pattern of key breast cancer markers. This evidence concerns the gene ERBB2 and breast carcinoma.